A New NEST: MDIC Leaders Discuss Relocation, National Evaluation System And More

 
• By Reed Miller
  
Generate a summary of this article
Listen to this article
Beta

Medical Device Innovation Consortium's CEO William Murray and VP for Technology Innovation Dawn Bardot sat down with Medtech Insight during the recent Design of Medical Devices conference in Minneapolis to discuss what their organization has been doing lately and some future focuses in the areas of regulatory science and device data collection.

Exclusive interview Q&A KOI

The Medical Device Innovation Consortium, a public-private partnership focused on regulatory science with deep FDA involvement, has been busy lately helping to start the Coordinating Center for the Medical Device National Evaluation System for health Technology (NEST), moving its headquarters from Minneapolis to the Washington, DC, area and continuing to facilitate collaborative research and development for better approaches to running medical device clinical trials.

The US FDA recently committed to spend $30m from device industry user fees to pilot NEST as part of the...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from R&D

Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Immersive Gaming; DHCoE AI Framework; Hello Heart

In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for depression and Sinaptica Therapeutics’ personalized neuromodulation for Alzheimer’s patients. Marion Webb discusses her interview with MindMaze’s John Krakauer on their gaming-focused DTx to help people recover from serious brain injuries. Elizabeth Orr introduces new voting members of the new Digital Health Advisory Committee and Natasha Barrow discusses Hello Heart’s new symptom-tracking feature in their heart-focused app.

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.  

MI-Business (Free-2): Prison Is the First Mental Health Visit for Many in Spain

 
• By Nabil

Spain has one of the highest incarceration rates in Europe, with 160 individuals imprisoned per 100,000 residents. In 2020, 43,494 people were incarcerated in facilities not managed by regional health authorities — essentially all regions except Catalonia, the Basque Country, and Navarra.

Crossject Tackles Needle Phobia In Emergency Settings

 
• By Anabel Costa-Ferreira

Patrick Alexandre, Crossject CEO, discusses crucial developments happening for Zeneo, a needle-free injector, functioning intramuscularly to administer medication in a tenth of a second.

More from Business

test carousel-Medtech

 
• By Saba Afreen

test carousel-Medtech

test carousel

 
• By Saba Afreen and Krsihna

test carousel-HBW

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.